Download PDF
Thromb Haemost 1975; 33(01): 077-080
DOI: 10.1055/s-0038-1647814
Meeting of the International Committee on Thrombosis and Haemostasis — Symposium on Heparin, Basel, Switzerland, September, 1974
Schattauer GmbH

Heparin Assay Methods for Control of in Vivo Heparin Effects[*]

H. C Godal
1   Haematological Research Laboratory, Ullevål Hospital, University Clinic, Oslo 1, Norway
› Author Affiliations
Further Information

Publication History

Publication Date:
02 July 2018 (online)

    Permissions and Reprints

 

* Presented at the Symposium on Heparin, Basel, Switzerland, September, 1974.


 

  • References

  • 1 Baden J. P, Sonnenfield M. The Bason test: A rapid bedside test for control of heparin therapy. Surgical Forum 1971; 22: 171.
    PubMedGoogle Scholar
  • 2 Biggs R, Denson K. W. E, Akman N, Borrett R, Hadden M. Antithrombin III antifactor Xa and heparin. British Journal of Haematology 1970; 19: 283.
    CrossrefPubMedGoogle Scholar
  • 3 Blakeley J. A. A rapid bedside method for the control of heparin therapy. Canadian Medical Association Journal 1968; 99: 1072.
    PubMedGoogle Scholar
  • 4 Eika C. Anticoagulant and platelet aggregating activities of heparin. Thrombosis Research 1973; 2: 349.
    CrossrefPubMedGoogle Scholar
  • 5 Eika C, Godal H. C, Kierulf P. Detection of small amounts of heparin by the thrombin clotting time. Lancet 1972; 11: 376.
    PubMedGoogle Scholar
  • 6 Godal H. C. A comparison between two heparin-neutralizing agents: Protamine and Polybrene. Scandinavian Journal of Clinical and Laboratory Investigation 1960; 12: 446.
    CrossrefPubMedGoogle Scholar
  • 7 Godal H. C. Heparin tolerance and the plasma proteins. Scandinavian Journal of Clinical and Laboratory Investigation 1961; 13: 314.
    CrossrefPubMedGoogle Scholar
  • 8 Goldberg E, O’Reilly M, Chaitiraphan S. Prevention of postbrachial- arteriotomy thrombosis. Lancet 1972; 11: 789.
    PubMedGoogle Scholar
  • 9 Grann V. J, Homewood K, Golden W. Polybrene neutralization as a rapid means of monitoring blood heparin. American Journal of Clinical Pathology 1972; 58: 26.
    CrossrefPubMedGoogle Scholar
  • 10 Hattersley P. Activated coagulation time of whole blood. Journal of American Medical Association 1966; 136: 436.
    PubMedGoogle Scholar
  • 11 Hirsh J, Gallus A. S. Letter to the Editor. New England Journal of Medicine 1973; 288: 1410.
    PubMedGoogle Scholar
  • 12 Holger-Madsen T, Schiöler M. Increased heparin resistance after operations measured by the heparin thrombin time. Acta Chirurgica Scandinavica 1960; 118: 257.
    PubMedGoogle Scholar
  • 13 Hougie C. The Lee and White test for coagulation time. American Journal of Clinical Pathology 1961; 36: 537.
    CrossrefPubMedGoogle Scholar
  • 14 Jaques L. B, Kavanagh L. W. Standardization of heparin for clinical use. Lancet 1972; 11: 1315.
    PubMedGoogle Scholar
  • 15 O’Shea M. J, Flute P. T, Pannell G. M. Laboratory control of heparin therapy. Journal of Clinical Pathology 1971; 24: 542.
    CrossrefPubMedGoogle Scholar
  • 16 Perkins H. A, Roles M. R, Torg B. Assay of blood coagulation factors in heparinized blood. Thrombosis et Diathesis Haemorrhagica 1964; 11: 254.
    PubMedGoogle Scholar
  • 17 Pitney W. R, Pettit J. E, Armstrong L. Control of heparin therapy. British Medical Journal 1970; 4: 139.
    CrossrefPubMedGoogle Scholar
  • 18 Struver G. P, Bittner L. D, Wall C. A. The use of the cephalin time (partial thromboplastin time) in anticoagulation therapy with heparin. Surgical Forum 1962; 13: 127.
    PubMedGoogle Scholar
  • 19 Yin E. T, Wessler S, Butler J. V. Plasma heparin: A unique practical submicrogram-sensitive assay. Journal of Laboratory and Clinical Medicine 1973; 81: 298.
    PubMedGoogle Scholar